Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies

NCT00310895

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: The University of Chicago Medical Center Chicago, Illinois, United States

Wayne State University, Karmanos Cancer Center Detroit, Michigan, United States

View Trial Details

Completed

AMG 102 and Avastin for Recurrent Malignant Glioma

NCT01113398

Conditions: Astrocytoma, Disease Attributes, Glioblastoma, +13 more
Locations: The Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States

View Trial Details

Completed

Mesalazine Effects in Sporadic Colorectal Adenoma Patients

NCT01894685

Conditions: Adenoma, Disease Attributes, Neoplasms, +6 more
Locations: University Medical Center Utrecht Utrecht, Netherlands

View Trial Details

Completed

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

NCT01321346

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +20 more
Locations: Childrens Hospital Los Angeles Los Angeles, California, United States

UCSF School of Medicine San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Miami Cancer Center Miami, Florida, United States

View all 20 locations

View Trial Details

Completed

Long-term Varenicline Treatment for Smoking Cessation

NCT00828113

Conditions: Behavior, Disease Attributes, Pathologic Processes, +3 more
Locations: Center for Tobacco Research and Intervention Madison, Wisconsin, United States

Center for Tobacco Research and Intervention Milwaukee, Wisconsin, United States

View Trial Details

Completed

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

NCT01421173

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)

NCT00116376

Conditions: Astrocytoma, Disease Attributes, Glioblastoma, +12 more
Locations: University of California at Los Angeles Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

The Brain Tumor Center at Duke, Duke University Medical Center Box 3624 Dumc, Trent Drive, Durham, North Carolina, United States

University of Texas, MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

Conditions: Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Cluster Headache and SPINK-1 Gene

NCT02585739

Conditions: Brain Diseases, Central Nervous System Diseases, Cluster Headache, +9 more
Locations: APHM Marseille, France

View Trial Details

Completed

Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005

NCT02271412

Conditions: Depressive Disorder, Depressive Disorder, Major, Disease Attributes, +6 more
Locations: PRA Health Sciences Marlton, New Jersey, United States

View Trial Details

Recurrence

Recurrence trial results

Related conditions